🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to evaluate the effect of the up-titra...
Status
Completed
Location
SGS Clinical Pharmacology Unit (located in ZNA Stuivenberg)
Start Date
2019-03-20
Trial ID
NCT03882255
Treatments Being Tested
This study consists of a single-dose pilot phase and a randomized, two-way ...
Status
Completed
Location
Simbec Research Limited
Start Date
2014-08
Trial ID
NCT02068235
Treatments Being Tested
This study will assess the efficacy, safety, and tolerability of ACT-128800...
Status
Completed
Location
Landeskrankenhaus - Universitätsklilnikum Graz, Allgemeine Dermatologie
Start Date
2008-10
Trial ID
NCT00852670
Treatments Being Tested
A multicenter, randomized, double-blind, placebo-controlled study to evalua...
Status
Recruiting
Location
Vanda Investigational Site
Start Date
2026-09
Trial ID
NCT07686081
This clinical study compares the efficacy, safety, and tolerability of ther...
Status
Terminated
Location
UAB Dpt of Neurology
Start Date
2017-03-30
Trial ID
NCT02907177
Chronic graft versus host diseasre (GVHD) is a serious reaction that might ...
Status
Terminated
Location
Multiple Locations
Start Date
2016-09-29
Trial ID
NCT02461134
Treatments Being Tested
The DELIVER-MS study seeks to answer the question: Does early treatment wit...
Status
Active Not Recruiting
Location
University of Colorado-Anschutz Medical Campus
Start Date
2019-01-03
Trial ID
NCT03535298
Treatments Being Tested
International clinical trial to compare ponesimod and teriflunomide in rela...
Status
Completed
Location
Investigator Site 8045
Start Date
2015-06-04
Trial ID
NCT02425644
Treatments Being Tested
FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) tar...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2018-05-02
Trial ID
NCT03500328
Treatments Being Tested
The purpose of this study is to evaluate the effect of steady-state carbama...
Status
Completed
Location
Clinical Pharmacology Unit
Start Date
2022-10-18
Trial ID
NCT05552196
Treatments Being Tested